{"id":2200,"date":"2022-10-27T15:55:07","date_gmt":"2022-10-27T12:55:07","guid":{"rendered":"https:\/\/larifan.eu\/?page_id=2200"},"modified":"2022-10-27T15:58:47","modified_gmt":"2022-10-27T12:58:47","slug":"larifan-application-in-practice","status":"publish","type":"page","link":"https:\/\/larifan.eu\/en\/larifan-application-in-practice\/","title":{"rendered":"Larifan application in practice"},"content":{"rendered":"<p>[vc_row overflow=&#8221;default&#8221; css=&#8221;.vc_custom_1643308766592{border-top-width: 60px !important;padding-bottom: 60px !important;}&#8221;][vc_column][vc_column_text]<\/p>\n<h2>APPLICATION IN PRACTICE dsRNA \u2013 LARIFAN<\/h2>\n<p>All Larifan brand products contain the active ingredient dsRNA Larifan.<\/p>\n<p><span style=\"font-size: 18px;\"><strong>In the status of drugs in its history, several forms of Larifan have been registered:<\/strong><\/span><\/p>\n<ul>\n<li>injections in Latvia (2004), then in Georgia (2010), Azerbaijan (2011) and Turkmenistan (2015),<\/li>\n<li>ointment form (0.05%) was registered in Latvia (1994 &#8211; 2004), in Georgia (2010)<\/li>\n<li>suppositories and pessaries in Georgia (2010)<\/li>\n<li>spray form in Georgia (2010)<\/li>\n<\/ul>\n<p><span style=\"font-size: 18px;\"><strong>In the status of medical goods distributed:<\/strong><\/span><\/p>\n<ul>\n<li>suppositories and pessaries in Latvia (2008-2011) and Azerbaijan (2010)<\/li>\n<li>ointment and spray in Azerbaijan (2010)<\/li>\n<\/ul>\n<p><strong><span style=\"font-size: 18px;\">In the status of cosmetic products:<\/span><\/strong><\/p>\n<ul>\n<li>lip balm, ointment (0.025%), spray, toothpaste in the European Union (2011) and Georgia (2013)<\/li>\n<li>lip balm, ointment (0.025%), toothpaste in Moldova (2014) and Vietnam (2016),<\/li>\n<li>cream for skin inflammation, lotion for sunburn, antibacterial and antiviral gel for hand disinfection &#8211; in the territory of the European Union (2016) and Georgia (2017)<\/li>\n<li>antibacterial and antiviral gel for hand disinfection with natural amber from the Baltic Sea &#8211; in the territory of the European Union (2017)<\/li>\n<\/ul>\n<p><span style=\"font-size: 18px;\"><strong>In the status of food products:<\/strong><\/span><\/p>\n<ul>\n<li>candies against sore throats (5 different flavors) in the European Union (2016) and Georgia (2017)<\/li>\n<\/ul>\n<p>In Larifan-containing cosmetic and food products, the active substance dsRNA Larifan is included in sub-therapeutic doses, which do not directly treat, but provide the mobilization of the body&#8217;s natural defenses, and thus provide some antiviral protection and immunomodulatory effects.<\/p>\n<p><span style=\"font-size: 18px;\"><img loading=\"lazy\" class=\" wp-image-2487 aligncenter\" src=\"https:\/\/larifan.eu\/wp-content\/uploads\/2022\/10\/3_Larifan_sadal\u0327as-300x125.jpeg\" alt=\"\" width=\"835\" height=\"348\" srcset=\"https:\/\/larifan.eu\/wp-content\/uploads\/2022\/10\/3_Larifan_sadal\u0327as-300x125.jpeg 300w, https:\/\/larifan.eu\/wp-content\/uploads\/2022\/10\/3_Larifan_sadal\u0327as-1024x427.jpeg 1024w, https:\/\/larifan.eu\/wp-content\/uploads\/2022\/10\/3_Larifan_sadal\u0327as-768x320.jpeg 768w, https:\/\/larifan.eu\/wp-content\/uploads\/2022\/10\/3_Larifan_sadal\u0327as-600x250.jpeg 600w, https:\/\/larifan.eu\/wp-content\/uploads\/2022\/10\/3_Larifan_sadal\u0327as.jpeg 1500w\" sizes=\"(max-width: 835px) 100vw, 835px\" \/><\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row overflow=&#8221;default&#8221; css=&#8221;.vc_custom_1643308766592{border-top-width: 60px !important;padding-bottom: 60px !important;}&#8221;][vc_column][vc_column_text] APPLICATION IN PRACTICE dsRNA \u2013 LARIFAN All Larifan brand products contain the active ingredient dsRNA Larifan. In the status of drugs in its history, several forms of Larifan have been registered: injections in Latvia (2004), then in Georgia&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"disable_featured_image":false},"aioseo_notices":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/pages\/2200"}],"collection":[{"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/comments?post=2200"}],"version-history":[{"count":2,"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/pages\/2200\/revisions"}],"predecessor-version":[{"id":2743,"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/pages\/2200\/revisions\/2743"}],"wp:attachment":[{"href":"https:\/\/larifan.eu\/en\/wp-json\/wp\/v2\/media?parent=2200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}